| Application no. and date | 17721109.1 (espacenet) (Federated) (European Patent Register), 20170428 | | Patent/reg. no. and date | DK/EP 3448416, 20220810 | | Publication date | 20190306 | | Priority no. and date | EP 16167458, 20160428, EP 16188262, 20160912 | | EP pub. no. and date |
EP 3448416 20190306 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | 2221034EPDK | | Inventor | HANSEN, Oluf Kristian Højbjerg, Novo Allé, 2880 Bagsværd, DK | | Representative | Kolster Oy Ab, Salmisaarenaukio 1,
PO Box 204,
00181 Helsinki, FI | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61P 3/10 (2006.01) , A61P 9/00 (2006.01) | | Title | SEMAGLUTID VED KARDIOVASKULÆRE TILSTANDE | | Int. application no. | EP2017060160 | | Int. publication no. | WO2017186896 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
